126 related articles for article (PubMed ID: 6168892)
21. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus.
Bukowski JF; Biron CA; Welsh RM
J Immunol; 1983 Aug; 131(2):991-6. PubMed ID: 6190947
[TBL] [Abstract][Full Text] [Related]
22. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
Cafruny WA; Bradley SE; Rowland RR
Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
[TBL] [Abstract][Full Text] [Related]
23. Lactate dehydrogenase-elevating virus induces anti-Golgi apparatus antibodies.
Weiland E; Weiland F; Grossmann A
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1983-91. PubMed ID: 3598563
[TBL] [Abstract][Full Text] [Related]
24. [Alterations in the isozyme spectrum and the activity of lactate dehydrogenase in development of Ehrlich ascites tumor].
Agatova AI
Vopr Med Khim; 1975; 21(3):276-81. PubMed ID: 1210105
[TBL] [Abstract][Full Text] [Related]
25. Acanthus ilicifolius plant extract prevents DNA alterations in a transplantable Ehrlich ascites carcinoma-bearing murine model.
Chakraborty T; Bhuniya D; Chatterjee M; Rahaman M; Singha D; Chatterjee BN; Datta S; Rana A; Samanta K; Srivastawa S; Maitra SK; Chatterjee M
World J Gastroenterol; 2007 Dec; 13(48):6538-48. PubMed ID: 18161924
[TBL] [Abstract][Full Text] [Related]
26. Reversible G2 block in the cell cycle of Ehrlich ascites carcinoma cells.
Lazebnik YA; Medvedeva ND; Zenin VV
Exp Cell Res; 1991 Jul; 195(1):247-54. PubMed ID: 2055271
[TBL] [Abstract][Full Text] [Related]
27. Mouse strain-specific central nervous system lesions associated with lactate dehydrogenase-elevating virus infection.
Stroop WG; Brinton MA
Lab Invest; 1983 Sep; 49(3):334-45. PubMed ID: 6887786
[TBL] [Abstract][Full Text] [Related]
28. Enhanced clearance of lactic dehydrogenase-5 in severe combined immunodeficiency (SCID) mice: effect of lactic dehydrogenase virus on enzyme clearance.
Hayashi T; Ozaki M; Mori I; Saito M; Itoh T; Yamamoto H
Int J Exp Pathol; 1992 Apr; 73(2):173-81. PubMed ID: 1571277
[TBL] [Abstract][Full Text] [Related]
29. [Capacity for differentiation and normalization of tumor cell populations transplanted into the anterior chamber. IV. Ehrlich ascites carcinoma].
Al-Rubey AK; Grigor'eva EG; Kulemina LIu; Shvemberger IN
Tsitologiia; 1984 Dec; 26(12):1376-83. PubMed ID: 6528361
[TBL] [Abstract][Full Text] [Related]
30. Purification and electron microscopy of lactic dehydrogenase virus of mice.
Horzinek MC; Wielink PS
J Gen Virol; 1975 Mar; 26(3):217-26. PubMed ID: 47383
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour.
Valadares MC; Klein SI; Guaraldo AM; Queiroz ML
Eur J Pharmacol; 2003 Jul; 473(2-3):191-6. PubMed ID: 12892838
[TBL] [Abstract][Full Text] [Related]
32. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
33. [On the behavior of the lactate dehydrogenase-activating virus from mouse tumors during autolysis].
BAYERLE H; GEORGII A; JAKOB P
Z Krebsforsch; 1962; 65():171-2. PubMed ID: 13967083
[No Abstract] [Full Text] [Related]
34. Immunoferon (AM3) enhances the activities of early-type interferon inducers and natural killer cells.
Moya P; Baixeras E; Barasoain I; Rojo JM; Ronda E; Alonso ML; Portolés A
Immunopharmacol Immunotoxicol; 1987; 9(2-3):243-56. PubMed ID: 2449486
[TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
36. Production of antiviral and migration inhibitory activities in the peritoneum of mice after inoculation with allogenic Ehrlich ascites tumor cells.
Lackovic V; Borecký L
Acta Biol Med Ger; 1979; 38(5-6):781-9. PubMed ID: 230674
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.
Fujioka T; Ishikura K; Hasegawa M; Ogyu K; Matsushita Y; Sato M; Sato F; Aoki H; Kubo T
Cancer Chemother Pharmacol; 1995; 36(1):7-12. PubMed ID: 7536641
[TBL] [Abstract][Full Text] [Related]
38. Infection of mice with lactate dehydrogenase-elevating virus leads to stimulation of autoantibodies.
Cafruny WA; Hovinen DE
J Gen Virol; 1988 Mar; 69 ( Pt 3)():723-9. PubMed ID: 2832535
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of mouse natural killer activity and induction of interferon by tumor cells in vivo.
Djeu JY; Huang KY; Herberman RB
J Exp Med; 1980 Apr; 151(4):781-9. PubMed ID: 6154760
[TBL] [Abstract][Full Text] [Related]
40. Mode of regulation of natural killer cell activity by interferon.
Minato N; Reid L; Cantor H; Lengyel P; Bloom BR
J Exp Med; 1980 Jul; 152(1):124-37. PubMed ID: 6156979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]